Trade Shows & Conferences in Boston, Massachusetts

International Academy of Cardiology, Annual Scientific Sessions 2014, 19th World Congress on Heart Disease

Date: 25-Jul-14 to 28-Jul-14
Deadline for submission of abstracts: February 25, 2014 The Congress will provide the opportunity for a comprehensive overview of the latest research developments in cardiovascular medicine, primarily in the areas of Molecular and Cellular Cardiology, Genetics of Heart Disease, Cardiac Imaging, Coronary Artery Disease, Peripheral Arterial Disease, Interventional Cardiology, Lipoprotein Disorders, Hypertension, Metabolic Syndrome, Heart Failure, Valvular Heart Disease, Diseases of the Aorta, Cardiac Arrhythmias and Electrophysiology, Implantable Cardiac Pacemakers and Cardioverter-Defibrillators, Sudden Cardiac Death, Pediatric Cardiology, Congenital Heart Disease, Cardiac Surgery, Heart Transplantation, Mechanical Circulatory Support and Measurement of Outcome and Quality of ...

ImVacS: The Immunotherapies and Vaccine Summit

Date: 11-Aug-14 to 14-Aug-14
ImVacS, The Immunotherapies and Vaccine Summit, brings together a global audience of vaccine researchers and developers of cancer immunotherapies for four focused meetings that explore the frontiers of immunology as the basis for patient treatment. Part 1 of the 9th annual "Novel Vaccines" meeting addresses "Adjuvants, TLRs and DNA Vaccines," while Part 2 explores "Emerging Vaccine Technologies." The 2nd annual "Immunomodulatory Therapeutic Antibodies for Cancer" meeting examines developments in the models and tools used in developing these emerging drug products, while the inaugural "Combination Cancer Immunotherapy" meeting focuses on the application of these antibody programs in combination with other treatment modalities. Target ...

The Bioprocessing Summit

Date: 18-Aug-14 to 22-Aug-14
The Bioprocessing Summit brings together international leaders to discuss today's bioprocess issues from cell line selection to manufacturing. The Summit provides practical details in a relaxed, congenial atmosphere that promotes information exchange and networking. This leading bioprocess meeting is hosted in Boston each summer along the lively and cosmopolitan harbor waterfront. Hundreds of bioprocess professionals come together each year at the Summit to share practical solutions for today's laboratory challenges with researchers from around the world.

Biorepositories and Sample Management Conference

Date: 08-Sep-14 to 10-Sep-14
7th Annual Biorepositories and Sample Management Conference Attend the 7th Annual Biorepositories and Sample Management Conference to examine the industry's most pressing topics, benchmark best practices with your peers and ultimately learn how to maximize the value of your biospecimens through quality-driven biobanking. New additions for 2014 include: 11 fresh case studies from companies like Pfizer, BMS, AZ, GSK, NIH and more, 2 Interactive pre-conference workshops on Informed Consent and Quality of Tissue Specimens for Research, peer-to-peer knowledge exchange using the event-specific networking tool on partnering360. Visit the website to learn more at www.biorepositoriesevent.com

7th Annual Biorepositories and Sample Management Conference

Date: 08-Sep-14 to 10-Sep-14
Attend the 7th Annual Biorepositories and Sample Management Conference to examine the industry's most pressing topics, benchmark best practices with your peers and ultimately learn how to maximize the value of your biospecimens through quality-driven biobanking. This year, the theme is quality, and how the quality of your samples can determine whether you will be forced to repeat clinical trials or reproduce their results as well as the potential fallout from adverse situations. Given the diversity of biobanks in the US, from academic institutions to research institutes and hospitals, any efforts at creating regulations or governing rules for them will require more than a "one-size-fits-all" model. Explore key topics: Next-Gen Sequencing: Enrich quality control and ...

Northeast Energy Summit 2014

Date: 17-Sep-14 to 19-Sep-14
Facing serious resource adequacy issues, and still reeling from last winter’s polar vortex disruption, major changes are coming to Northeastern power and gas markets. Proposals have been made to provide firm gas supply contracts through the ISOs, revamp central capacity markets to provide more incentives for new generation, establish “energy highway” and similar programs, and to radically change the way electricity is procured, distributed and regulated. With these new rules in the works, opportunities will open up for a wide variety of energy market players. How much generation and infrastructure will be built? How will power pricing, market operations and plant valuations be affected? What impacts will demand response (DR), microgrid and energy storage technologies have on the Northeast ...

Targeting Ocular Disorders

Date: 06-Oct-14 to 07-Oct-14
With the aging of the population, the need for treatments of ocular diseases and disorders has become more important than ever. Increasingly high incidences of age-related macular degeneration (AMD), glaucoma, diabetic retinopathy and ocular inflammatory diseases demand better, more effective and innovative treatments. If we are to maintain the quality of life for this aging population, the preservation of vision is critical. This conference will address targeting of ophthalmic medications and treatments and will provide the latest results in the field, along with novel and emerging targets that hold promise in treating these quality of life threats.

Discovery on Target

Date: 08-Oct-14 to 10-Oct-14
Cambridge Healthtech Institute will host its 12th Annual Discovery on Target event showcasing current and emerging "hot" targets for the pharmaceutical industry, October 8-10, 2014 in Boston, MA. Spanning three days, the meeting attracts over 900+ attendees (from 24 countries), composed of scientists/technologists, executives, directors, and managers from biopharma, academic, and healthcare organizations. In 2014 the event is comprised of 14 conference tracks which include Epigenetic Readers, Ubiquitin Proteasome, Big Data Discovery, GPCR Drug Discovery, RNAi-Screens-Functional-Genomics, PPI Targets, Protein-Targets, Histone-Methyltransferases-Demethylases, Drug Transporters, Maximizing Efficiency, GPCR Therapeutics, Genomics Screening, Cancer Metabolism and Membrane Production. ...

Re-Entering Antibacterial Drug Development Summit

Date: 27-Oct-14 to 29-Oct-14
Several factors including diminishing financial return, lack of new discovery platforms and others, had a cooling effect on pharmaceutical companies' activity in the area of antibacterial drug development. At the same time, we are witnessing the wide spread of resistant bacteria, leading to untreatable infections. "We are facing a huge crisis worldwide not having an antibiotics pipeline," said Dr. Janet Woodcock, Director of CDER at FDA, in her recent interview to NYT. The governments of European countries and the United States have created several incentives for the industry to rise to the challenge. Therefore, many companies are exploring the opportunities to start or re-open their antibacterial departments, or to stimulate the existing research and development. Cambridge ...

Targeting Tick-Borne Diseases

Date: 29-Oct-14 to 30-Oct-14
The rapid expansion of tick-borne illness in the Americas and Europe poses great challenges for the prevention and treatment of these diseases, in both humans and animals. Though Lyme Disease continues to be the predominant disease (with estimates of as many as 300,000 new cases every year in the US), new and emerging illnesses are increasingly reported. The cost for treatment of these diseases continues to rise. As humans and animals spend more time in wooded areas, the threat becomes even more urgent. This conference will address the newest science in the pathogenesis of these diseases, along with the latest research into prevention and treatment of these crippling illnesses.